Suppr超能文献

具有透明细胞特征的非小细胞肺癌:31 例临床病理、免疫组织化学和分子研究。

Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases.

机构信息

Department of Pathology, Rutgers University, New Jersey Medical School, Newark, NJ, 07103, USA.

Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Virchows Arch. 2024 Jul;485(1):83-96. doi: 10.1007/s00428-024-03833-5. Epub 2024 May 30.

Abstract

Non-small cell lung carcinoma with predominantly clear cell features is a rare histologic presentation of lung carcinoma. We have examined 31 cases of lung carcinomas showing extensive clear cell features. The patients were 10 women and 21 men aged 47-92 years (mean: 70 years). The tumors showed a predilection for the right upper and lower lobes and measured from 0.8 to 9.5 cm (mean: 4.2 cm). By immunohistochemistry, 9 cases were typed as adenocarcinoma, 19 cases as squamous cell carcinoma, and 3 showed a "null" phenotype with complete loss of markers for adenocarcinoma or squamous cell carcinoma. Most cases that typed as adenocarcinoma showed a solid growth pattern. A subset of the solid adenocarcinoma cases showed a distinctive "pseudosquamous" morphology. Next-generation sequencing was performed in 20 cases and showed a variety of molecular alterations. The most common abnormalities were found in the TP53 gene (9 cases), FGFR gene family (8 cases), KRAS (5 cases), AKT1 (5 cases), and BRAF (3 cases). Clinical follow-up was available in 21 patients; 16/21 patients died of their tumors from 6 months to 12 years after initial diagnosis (mean: 4.2 years, median: 1.5 years). Four patients were alive and well from 4 to 27 years (mean: 11.5 years, median: 7.5 years); all were pathologic stage 1 or 2. NSCLC with clear cell features can display aggressive behavior and needs to be distinguished from various other tumors of the lung that can show clear cell morphology. The identification of targetable molecular alterations in some of these tumors may be of value for therapeutic management.

摘要

以透明细胞为主的非小细胞肺癌是一种罕见的肺癌组织学表现。我们检查了 31 例广泛透明细胞特征的肺癌病例。这些患者为 10 名女性和 21 名男性,年龄 47-92 岁(平均:70 岁)。肿瘤倾向于发生于右上叶和下叶,大小从 0.8 至 9.5cm(平均:4.2cm)。免疫组织化学检查显示,9 例为腺癌,19 例为鳞状细胞癌,3 例表现为“空”表型,完全缺乏腺癌或鳞状细胞癌的标志物。大多数被归类为腺癌的病例表现为实体生长模式。一部分实性腺癌病例表现出独特的“假鳞状”形态。20 例进行了下一代测序,显示出多种分子改变。最常见的异常发生在 TP53 基因(9 例)、FGFR 基因家族(8 例)、KRAS(5 例)、AKT1(5 例)和 BRAF(3 例)。21 例患者可获得临床随访;16/21 例患者在初始诊断后 6 个月至 12 年内(平均:4.2 年,中位数:1.5 年)死于肿瘤。4 例患者在 4 至 27 年内(平均:11.5 年,中位数:7.5 年)存活且情况良好;所有患者均为病理分期 1 或 2 期。具有透明细胞特征的 NSCLC 可能表现出侵袭性行为,需要与其他具有透明细胞形态的肺部肿瘤相鉴别。这些肿瘤中某些肿瘤的可靶向分子改变的鉴定可能对治疗管理具有价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验